Souhaitez-vous accéder aux communiqués récents ?

Today, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash...

Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the...

Novozymes has renewed its climate targets and by 2030 will reduce its absolute CO2 emissions across its operation by 75% and reduce its absolute CO2 emissions from its supply chain by 35%. By 2050,...

COPENHAGEN, Denmark – November 10, 2022. Novozymes, the world leader in biological solutions, and LinusBio (Linus Biotechnology Inc.), a leader in precision exposome sequencing, today announced the...

Novozymes delivered 9% organic sales growth in the first nine months of 2022 and 6% organic sales growth in the third quarter. As announced on October 7, the full-year organic sales growth outlook was...

Please read the full announcement in PDF Attachment 2022_27_Q32022_CompanyAnnouncement ...

Novozymes Named EPA Safer Choice Partner of the Year for Second Consecutive Year World’s Leading Biotech Powerhouse Recognized for Providing and Advocating for Ingredients that Create Safer...

Strong momentum in organic sales growth; full-year outlook lifted to 8-9%; continued full commitment to long-term financial targets Please read the full announcement in PDF Attachment ...

Novozymes delivered solid earnings and double-digit organic sales growth in both the first half and in the second quarter. Despite the volatile market environment, the company narrows its full-year...

Please read the full announcement in PDF Attachment 2022_25_Q22022_CompanyAnnouncement ...